Cargando…
The Heterogeneous Multiple Sclerosis Lesion: How Can We Assess and Modify a Degenerating Lesion?
Multiple sclerosis (MS) is a heterogeneous disease of the central nervous system that is governed by neural tissue loss and dystrophy during its progressive phase, with complex reactive pathological cellular changes. The immune-mediated mechanisms that promulgate the demyelinating lesions during rel...
Autores principales: | Ellen, Olivia, Ye, Sining, Nheu, Danica, Dass, Mary, Pagnin, Maurice, Ozturk, Ezgi, Theotokis, Paschalis, Grigoriadis, Nikolaos, Petratos, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342336/ https://www.ncbi.nlm.nih.gov/pubmed/37446290 http://dx.doi.org/10.3390/ijms241311112 |
Ejemplares similares
-
Modulation of the Microglial Nogo-A/NgR Signaling Pathway as a Therapeutic Target for Multiple Sclerosis
por: Nheu, Danica, et al.
Publicado: (2022) -
How does Nogo receptor influence demyelination and remyelination in the context of multiple sclerosis?
por: Rashidbenam, Zahra, et al.
Publicado: (2023) -
Thyroid hormone-dependent oligodendroglial cell lineage genomic and non-genomic signaling through integrin receptors
por: Emamnejad, Rahimeh, et al.
Publicado: (2022) -
The Diversity of Astrocyte Activation during Multiple Sclerosis: Potential Cellular Targets for Novel Disease Modifying Therapeutics
por: Barmpagiannos, Konstantinos, et al.
Publicado: (2023) -
Can We Design a Nogo Receptor-Dependent Cellular Therapy to Target MS?
por: Kim, Min Joung, et al.
Publicado: (2018)